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Introduction Endoscopic resection (ER) is an accepted treat-
ment of early upper gastrointestinal neoplasia in Europe, but 
surgery remains the gold standard in the UK due to lack of 
data. We started an upper gastrointestinal ER service in 2005 
and are reporting our 6 year outcome data. We serve six differ-
ent regional cancer centres.
Methods We analysed our database of all upper gastrointes-
tinal (UGI) endoscopic resection procedures performed at our 
centre for the period 2005–2010. All procedures were carried 
out by a single skilled endoscopist. Demographic data, histol-
ogy, procedure success, long-term outcome and complications 
were assessed.
Results We have performed 160 UGI ER procedures (108 
oesophageal (O), 29 gastric (G), 33 duodenal/ampullary (D)) in 
127 patients (O=75, G=25, D=27).
Mean age was 65.9 years (range 25–94). A mean of 1.32 UGI 
ER procedures were performed per patient (range 1–5). All 
neoplastic cases were diagnosed as high grade dysplasia or 
intramucosal cancer prior to EMR.
Overall complication rate was 5.0%. Specifi c complications 
were four procedural bleeds and two delayed bleeds (all con-
trolled endoscopically) one full thickness perforation clipped 
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endoscopically and one episode of pancreatitis. There were no 
cases of procedure related mortality.
25 patients (19.7%) were upstaged, having been found to 
have sm1 invasion or deeper on histological examination of 
the initial ER specimen. This group were considered for radi-
cal treatment if fi t, or conservative management if unfi t or 
through patient choice. 16 patients (O=11, G=4, D=1) pro-
ceeded to radical surgery, of which 2 patients died of postop-
erative complications and 2 patients died of local recurrence; 
the other 12 remain well. 2 patients received chemo/radio-
therapy; 1 died of advanced oesophageal cancer, the other 
remains well.
Of the remaining 102 patients complete local remission was 
achieved in 79.4% of cases following a single ER procedure, 
and in 97.1% overall. After a mean 2.57 years follow-up; 4% 
of all patients are known to have recurrence or metachronous 
disease and are awaiting further ER.
Development of our service has potentially led to a cost saving 
of £91 270 per year, plus 170 bed days saved per year through 
reduced requirement for radical surgery.
Conclusion
1.  Our data demonstrates the long-term feasibility, effi cacy 
and safety of an innovative ER service.
2.  It provides valuable information about the number and 
type of patients requiring this service helping inform 
future planning and commissioning.
3.  Our data demonstrates signifi cant cost savings for the NHS.
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